0 577

Cited 12 times in

Inhibitory Effect of Chrysin (5,7-Dihydroxyflavone) on Experimental Choroidal Neovascularization in Rats.

DC Field Value Language
dc.contributor.author이성철-
dc.contributor.author이지환-
dc.date.accessioned2017-02-27T08:12:01Z-
dc.date.available2017-02-27T08:12:01Z-
dc.date.issued2016-
dc.identifier.issn0030-3747-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/147109-
dc.description.abstractPURPOSE: The aim of this study was to evaluate the effect of chrysin on laser-induced experimental choroidal neovascularization (CNV) in a rat model. METHODS: Male brown Norway rats were anesthetized, and a diode laser was used to break Bruch's membrane. One week later, each rat was intravitreally injected with 5 µl of 15 mg/ml chrysin, and CNV development was determined by fluorescein angiography at 2 weeks. The effect of chrysin on experimental CNV was assessed by fluorescein angiography and histology. RESULTS: Two weeks after laser treatment, the intensity of fluorescein leakage from the photocoagulated lesions decreased significantly compared with the control group (p = 0.044). When the lesions were categorized into low- and high-leakage groups, there was a significant correlation between chrysin treatment and degree of leakage (p = 0.028). Compared with the chrysin-treated group, the relative risk of developing high-leakage lesions in the control group was 3.18. The mean CNV thickness was significantly thinner in chrysin-treated eyes than in control eyes (34.13 ±.0.88 vs. 37.76 ± 0.90 μm, p = 0.005). CONCLUSION: Chrysin has an inhibitory effect on CNV in an experimental rat model, indicating that chrysin should be further evaluated for its potential as a therapy for CNV in age-related macular degeneration and in other vision-threatening conditions associated with CNV.-
dc.description.statementOfResponsibilityrestriction-
dc.format.extent49~55-
dc.languageEnglish-
dc.publisherKarger-
dc.relation.isPartOfOPHTHALMIC RESEARCH-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAnimals-
dc.subject.MESHChoroidal Neovascularization/drug therapy*-
dc.subject.MESHChoroidal Neovascularization/pathology-
dc.subject.MESHDisease Models, Animal-
dc.subject.MESHFlavonoids/administration & dosage*-
dc.subject.MESHFluorescein Angiography-
dc.subject.MESHFundus Oculi-
dc.subject.MESHIntravitreal Injections-
dc.subject.MESHMale-
dc.subject.MESHRats-
dc.subject.MESHRats, Inbred BN-
dc.subject.MESHTreatment Outcome-
dc.subject.MESHVascular Endothelial Growth Factor A/antagonists & inhibitors-
dc.titleInhibitory Effect of Chrysin (5,7-Dihydroxyflavone) on Experimental Choroidal Neovascularization in Rats.-
dc.typeArticle-
dc.publisher.locationSwitzerland-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Ophthalmology-
dc.contributor.googleauthorSong J.H.-
dc.contributor.googleauthorKim Y.H.-
dc.contributor.googleauthorLee S.C.-
dc.contributor.googleauthorKim M.H.-
dc.contributor.googleauthorLee J.H.-
dc.identifier.doi10.1159/000444929-
dc.contributor.localIdA02873-
dc.contributor.localIdA03222-
dc.relation.journalcodeJ02428-
dc.identifier.eissn1423-0259-
dc.identifier.pmid27058958-
dc.identifier.urlhttp://www.karger.com/Article/Abstract/444929-
dc.subject.keywordChrysinFluorescein-
dc.subject.keywordangiographyIntravitreal-
dc.subject.keywordinjectionLaser-induced-
dc.subject.keywordchoroidal-
dc.subject.keywordneovascularization-
dc.contributor.alternativeNameLee, Sung Chul-
dc.contributor.alternativeNameLee, Ji Hwan-
dc.contributor.affiliatedAuthorLee, Sung Chul-
dc.contributor.affiliatedAuthorLee, Ji Hwan-
dc.citation.volume56-
dc.citation.number1-
dc.citation.startPage49-
dc.citation.endPage55-
dc.identifier.bibliographicCitationOPHTHALMIC RESEARCH, Vol.56(1) : 49-55, 2016-
dc.date.modified2017-02-24-
dc.identifier.rimsid47141-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.